Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-19-004927
Filing Date
2019-09-23
Accepted
2019-09-23 16:12:36
Documents
1
Period of Report
2019-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 10527
  Complete submission text file 0001562180-19-004927.txt   12102
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REGENXBIO INC. 9600 BLACKWELL ROAD, SUITE 210 ROCKVILLE MD 20850
Business Address
Mills Kenneth T. (Reporting) CIK: 0001652824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37553 | Film No.: 191108166